Interaction of cyclosporin A and etoposide. Clinical and in vitro assessment in blast phase of chronic myeloid leukaemia

Clinical and Laboratory Haematology

Volumn 19, Issue 3, 1997, Pages 215-217

  Maia, R C ^a,b   Noronha, H ^a   Vasconcelos, F C ^b   Rumjanek, V M ^c  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b Therapy and Technology Development Section   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Blast crises of chronic myelogeneous leukaemia; Cyclosporin A; Etoposide; Multidrug resistance

Indexed keywords

CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; GLYCOPROTEIN P; MITOXANTRONE;

ADULT; ARTICLE; BLAST CELL; BLAST CELL CRISIS; CASE REPORT; CHRONIC MYELOID LEUKEMIA; COMBINATION CHEMOTHERAPY; DRUG INFUSION; DRUG POTENTIATION; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LEUKOSTASIS; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLAST CRISIS; CYCLOSPORINE; DRUG INTERACTIONS; ETOPOSIDE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOID, CHRONIC; MALE;

EID: 0030885406     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2257.1997.tb00011.x     Document Type: Article

References (11)

1. Cordell L.J., Falini B., Erber W.N. et al. (1984) Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). Journal Histochemical Cytochemical 32, 219-229.
2. Hainsworth J.D. & Greco F.A. (1995) Etoposide: twenty years later. Annals of Oncology 6, 525-341.
3. Kantarjian H.M., Talpaz M., Kontoyiannis D. et al. (1992) Treatment of chronic myelogenous leukaemia accelerated and blastic phase with daunorubicin, high-dose citarabine, and granulocyte-macrophage colony stimulating factor. Journal of Clinical Oncology 10, 398-405.
4. Kreis W. & Soricelli A. (1979) Cyclosporins: immunosuppressive agents with antitumour activity. Experimentia 35, 1506-1508.
5. Kuwazuru Y., Yoshimura A., Hanada S. et al (1990) Expression of the multidrug transporter, P-glycoprotein, in chronic myelogeneous leukaemia cells in blast crises. British Journal of Haemathology 74, 24-29.
6. Lum B.L., Kaubisch S., Yahanda A.M. et al. (1992) Alteration of etoposide pharmacokinetics and pharmacodynamics by ciclosporin in a phase I trial to modulate multidrug resistence. Journal of Clinical Oncology 10, 1635-1642.
7. Pastan I. & Gottesman M.M. (1991) Multidrug resistance. Annals Review Medicine 42, 277-286.
8. Preisler H.D., Raza A., Higby D. et al. (1984) Treatment of myeloid blastic crisis of chronic myelogenous leukaemia. Cancer Treatment Report 68, 1351-1355.
9. Raderer M. & Scheithauer W. (1993) Clinical trials of agents that reverse multidrug resistance. Cancer 72, 3553-3563.
10. Sato H., Gottesman M.M., Goldestein L.J. (1990) Expression of the multidrug resistance gene in myeloid leukaemias. Leukemia Research 14, 11-4.
11. Yahanda A.M., Adler K.M., Fisher G.A. et al. (1992) Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance. Journal of Clinical Oncology 10, 1624-1634.